CRIS Curis Inc

Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers.

$7.62  +0.08 (1.00%)
As of 06/21/2021 15:59:50 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  91,535,272
Average volume:  3,522,707
Market cap:   $698,414,125
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    231269200
ISIN:        US2312692005
Sedol:      BDGGJ94
Valuation   (See tab for details)
PE ratio:   -22.91
PB ratio:   5.66
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy